Loading…
N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction
Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-terminal pro-B-ty...
Saved in:
Published in: | PloS one 2020-12, Vol.15 (12), p.e0243213 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 12 |
container_start_page | e0243213 |
container_title | PloS one |
container_volume | 15 |
creator | Jones, Erika Wei, Janet Nelson, Michael D Bakir, May Mehta, Puja K Shufelt, Chrisandra Minissian, Margo Sharif, Behzad Pepine, Carl J Handberg, Eileen Cook-Wiens, Galen Sopko, George Bairey Merz, C. Noel |
description | Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used to evaluate HF and myocardial ischemia. Relationships between NT-proBNP and CMD are not well defined in this population. We evaluated resting NT-proBNP levels in 208 women with symptoms and signs of ischemic heart disease, preserved LVEF and no obstructive CAD undergoing clinically indicated invasive coronary flow reserve (CFR) as a measure of CMD-related ischemia and resting left ventricular end-diastolic pressure (LVEDP). Chi-square testing was used for categorical variables and ANOVA or Kruskal-Wallis tests were used for continuous variables. Overall, 79% had an elevated resting LVEDP, and mean NT-proBNP was 115 ± 158 pg/mL. NT-proBNP levels correlated directly with age (r = 0.28, p = |
doi_str_mv | 10.1371/journal.pone.0243213 |
format | article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_incontextgauss_ISR_A643673257</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A643673257</galeid><sourcerecordid>A643673257</sourcerecordid><originalsourceid>FETCH-LOGICAL-g997-8596d73a64f547f57a1d604418ee917cc17ef3331443bff5974e842518906cb43</originalsourceid><addsrcrecordid>eNqFj8Fu2zAMho2hBZZ2fYMdeOrQgzPLkiW7tyxrtwBFC7RBdgwUmY4V2JIhydnylnukOu2CpadeSIL8_p9kFH0myZhQQb5ubO-MbMadNThOUkZTQj9EI1LQNOZpQk-O6o_RmfebJMlozvko-nsfz9G1epBD52z8LQ67DsHI4HTvMGgFHXZBlwjSlKCss0a6HbRaObuVXvWNdFDufNUbFbQ1oA38ti0OUYd68ESPbosl4AZfgcrJl-IaJuCwsy4MLdtCqBF-7ZVfPMy8qrHVEp52phyGCDdb2fRyr4unhyMWh_3f_-__FJ1WsvF48S-fR_Pbm_n0Z3z38GM2ndzF66IQcZ4VvBRUclZlTFSZkKTkCWMkRyyIUIoIrCilhDG6qqqsEAxzlmYkLxKuVoyeR1evtmvZ4FIbZU3AP2Ete--Xs6fH5YQzygVNM_EO-7B4y14esTXKJtTeNv3-NX8MPgNqdKBZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Jones, Erika ; Wei, Janet ; Nelson, Michael D ; Bakir, May ; Mehta, Puja K ; Shufelt, Chrisandra ; Minissian, Margo ; Sharif, Behzad ; Pepine, Carl J ; Handberg, Eileen ; Cook-Wiens, Galen ; Sopko, George ; Bairey Merz, C. Noel</creator><creatorcontrib>Jones, Erika ; Wei, Janet ; Nelson, Michael D ; Bakir, May ; Mehta, Puja K ; Shufelt, Chrisandra ; Minissian, Margo ; Sharif, Behzad ; Pepine, Carl J ; Handberg, Eileen ; Cook-Wiens, Galen ; Sopko, George ; Bairey Merz, C. Noel</creatorcontrib><description>Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used to evaluate HF and myocardial ischemia. Relationships between NT-proBNP and CMD are not well defined in this population. We evaluated resting NT-proBNP levels in 208 women with symptoms and signs of ischemic heart disease, preserved LVEF and no obstructive CAD undergoing clinically indicated invasive coronary flow reserve (CFR) as a measure of CMD-related ischemia and resting left ventricular end-diastolic pressure (LVEDP). Chi-square testing was used for categorical variables and ANOVA or Kruskal-Wallis tests were used for continuous variables. Overall, 79% had an elevated resting LVEDP, and mean NT-proBNP was 115 ± 158 pg/mL. NT-proBNP levels correlated directly with age (r = 0.28, p = <0.0001), and indirectly with body mass index (r = -0.21, p = 0.0006), but did not independently associate with CFR. When stratified by NT-proBNP thresholds, higher NT-proBNP was initially associated with lower CFR, which did not persist with adjustment for multiple testing (p = 0.01 and 0.36, respectively). Among women with symptoms and signs of ischemia, preserved LVEF, no obstructive CAD, and undergoing clinically indicated functional coronary angiography (FCA) for suspected CMD, while a majority had elevated resting LVEDP, we failed to find an independent association between CFR and NT-proBNP, although stratified clinical thresholds may relate to lower CFR. Further work is needed to investigate if these findings support the hypothesis that CMD-related ischemia may be a precursor to HFpEF.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0243213</identifier><language>eng</language><publisher>Public Library of Science</publisher><subject>Analysis ; Demographic aspects ; Diagnosis ; Forecasts and trends ; Health aspects ; Heart failure ; Myocardial ischemia ; Natriuretic peptides ; Risk factors ; Women's health</subject><ispartof>PloS one, 2020-12, Vol.15 (12), p.e0243213</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Jones, Erika</creatorcontrib><creatorcontrib>Wei, Janet</creatorcontrib><creatorcontrib>Nelson, Michael D</creatorcontrib><creatorcontrib>Bakir, May</creatorcontrib><creatorcontrib>Mehta, Puja K</creatorcontrib><creatorcontrib>Shufelt, Chrisandra</creatorcontrib><creatorcontrib>Minissian, Margo</creatorcontrib><creatorcontrib>Sharif, Behzad</creatorcontrib><creatorcontrib>Pepine, Carl J</creatorcontrib><creatorcontrib>Handberg, Eileen</creatorcontrib><creatorcontrib>Cook-Wiens, Galen</creatorcontrib><creatorcontrib>Sopko, George</creatorcontrib><creatorcontrib>Bairey Merz, C. Noel</creatorcontrib><title>N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction</title><title>PloS one</title><description>Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used to evaluate HF and myocardial ischemia. Relationships between NT-proBNP and CMD are not well defined in this population. We evaluated resting NT-proBNP levels in 208 women with symptoms and signs of ischemic heart disease, preserved LVEF and no obstructive CAD undergoing clinically indicated invasive coronary flow reserve (CFR) as a measure of CMD-related ischemia and resting left ventricular end-diastolic pressure (LVEDP). Chi-square testing was used for categorical variables and ANOVA or Kruskal-Wallis tests were used for continuous variables. Overall, 79% had an elevated resting LVEDP, and mean NT-proBNP was 115 ± 158 pg/mL. NT-proBNP levels correlated directly with age (r = 0.28, p = <0.0001), and indirectly with body mass index (r = -0.21, p = 0.0006), but did not independently associate with CFR. When stratified by NT-proBNP thresholds, higher NT-proBNP was initially associated with lower CFR, which did not persist with adjustment for multiple testing (p = 0.01 and 0.36, respectively). Among women with symptoms and signs of ischemia, preserved LVEF, no obstructive CAD, and undergoing clinically indicated functional coronary angiography (FCA) for suspected CMD, while a majority had elevated resting LVEDP, we failed to find an independent association between CFR and NT-proBNP, although stratified clinical thresholds may relate to lower CFR. Further work is needed to investigate if these findings support the hypothesis that CMD-related ischemia may be a precursor to HFpEF.</description><subject>Analysis</subject><subject>Demographic aspects</subject><subject>Diagnosis</subject><subject>Forecasts and trends</subject><subject>Health aspects</subject><subject>Heart failure</subject><subject>Myocardial ischemia</subject><subject>Natriuretic peptides</subject><subject>Risk factors</subject><subject>Women's health</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFj8Fu2zAMho2hBZZ2fYMdeOrQgzPLkiW7tyxrtwBFC7RBdgwUmY4V2JIhydnylnukOu2CpadeSIL8_p9kFH0myZhQQb5ubO-MbMadNThOUkZTQj9EI1LQNOZpQk-O6o_RmfebJMlozvko-nsfz9G1epBD52z8LQ67DsHI4HTvMGgFHXZBlwjSlKCss0a6HbRaObuVXvWNdFDufNUbFbQ1oA38ti0OUYd68ESPbosl4AZfgcrJl-IaJuCwsy4MLdtCqBF-7ZVfPMy8qrHVEp52phyGCDdb2fRyr4unhyMWh_3f_-__FJ1WsvF48S-fR_Pbm_n0Z3z38GM2ndzF66IQcZ4VvBRUclZlTFSZkKTkCWMkRyyIUIoIrCilhDG6qqqsEAxzlmYkLxKuVoyeR1evtmvZ4FIbZU3AP2Ete--Xs6fH5YQzygVNM_EO-7B4y14esTXKJtTeNv3-NX8MPgNqdKBZ</recordid><startdate>20201203</startdate><enddate>20201203</enddate><creator>Jones, Erika</creator><creator>Wei, Janet</creator><creator>Nelson, Michael D</creator><creator>Bakir, May</creator><creator>Mehta, Puja K</creator><creator>Shufelt, Chrisandra</creator><creator>Minissian, Margo</creator><creator>Sharif, Behzad</creator><creator>Pepine, Carl J</creator><creator>Handberg, Eileen</creator><creator>Cook-Wiens, Galen</creator><creator>Sopko, George</creator><creator>Bairey Merz, C. Noel</creator><general>Public Library of Science</general><scope>IOV</scope><scope>ISR</scope></search><sort><creationdate>20201203</creationdate><title>N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction</title><author>Jones, Erika ; Wei, Janet ; Nelson, Michael D ; Bakir, May ; Mehta, Puja K ; Shufelt, Chrisandra ; Minissian, Margo ; Sharif, Behzad ; Pepine, Carl J ; Handberg, Eileen ; Cook-Wiens, Galen ; Sopko, George ; Bairey Merz, C. Noel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g997-8596d73a64f547f57a1d604418ee917cc17ef3331443bff5974e842518906cb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Analysis</topic><topic>Demographic aspects</topic><topic>Diagnosis</topic><topic>Forecasts and trends</topic><topic>Health aspects</topic><topic>Heart failure</topic><topic>Myocardial ischemia</topic><topic>Natriuretic peptides</topic><topic>Risk factors</topic><topic>Women's health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jones, Erika</creatorcontrib><creatorcontrib>Wei, Janet</creatorcontrib><creatorcontrib>Nelson, Michael D</creatorcontrib><creatorcontrib>Bakir, May</creatorcontrib><creatorcontrib>Mehta, Puja K</creatorcontrib><creatorcontrib>Shufelt, Chrisandra</creatorcontrib><creatorcontrib>Minissian, Margo</creatorcontrib><creatorcontrib>Sharif, Behzad</creatorcontrib><creatorcontrib>Pepine, Carl J</creatorcontrib><creatorcontrib>Handberg, Eileen</creatorcontrib><creatorcontrib>Cook-Wiens, Galen</creatorcontrib><creatorcontrib>Sopko, George</creatorcontrib><creatorcontrib>Bairey Merz, C. Noel</creatorcontrib><collection>Gale In Context: Opposing Viewpoints</collection><collection>Science in Context</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jones, Erika</au><au>Wei, Janet</au><au>Nelson, Michael D</au><au>Bakir, May</au><au>Mehta, Puja K</au><au>Shufelt, Chrisandra</au><au>Minissian, Margo</au><au>Sharif, Behzad</au><au>Pepine, Carl J</au><au>Handberg, Eileen</au><au>Cook-Wiens, Galen</au><au>Sopko, George</au><au>Bairey Merz, C. Noel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction</atitle><jtitle>PloS one</jtitle><date>2020-12-03</date><risdate>2020</risdate><volume>15</volume><issue>12</issue><spage>e0243213</spage><pages>e0243213-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used to evaluate HF and myocardial ischemia. Relationships between NT-proBNP and CMD are not well defined in this population. We evaluated resting NT-proBNP levels in 208 women with symptoms and signs of ischemic heart disease, preserved LVEF and no obstructive CAD undergoing clinically indicated invasive coronary flow reserve (CFR) as a measure of CMD-related ischemia and resting left ventricular end-diastolic pressure (LVEDP). Chi-square testing was used for categorical variables and ANOVA or Kruskal-Wallis tests were used for continuous variables. Overall, 79% had an elevated resting LVEDP, and mean NT-proBNP was 115 ± 158 pg/mL. NT-proBNP levels correlated directly with age (r = 0.28, p = <0.0001), and indirectly with body mass index (r = -0.21, p = 0.0006), but did not independently associate with CFR. When stratified by NT-proBNP thresholds, higher NT-proBNP was initially associated with lower CFR, which did not persist with adjustment for multiple testing (p = 0.01 and 0.36, respectively). Among women with symptoms and signs of ischemia, preserved LVEF, no obstructive CAD, and undergoing clinically indicated functional coronary angiography (FCA) for suspected CMD, while a majority had elevated resting LVEDP, we failed to find an independent association between CFR and NT-proBNP, although stratified clinical thresholds may relate to lower CFR. Further work is needed to investigate if these findings support the hypothesis that CMD-related ischemia may be a precursor to HFpEF.</abstract><pub>Public Library of Science</pub><doi>10.1371/journal.pone.0243213</doi><tpages>e0243213</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2020-12, Vol.15 (12), p.e0243213 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_gale_incontextgauss_ISR_A643673257 |
source | Publicly Available Content Database; PubMed Central |
subjects | Analysis Demographic aspects Diagnosis Forecasts and trends Health aspects Heart failure Myocardial ischemia Natriuretic peptides Risk factors Women's health |
title | N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T21%3A02%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=N-Terminal%20pro-B-type%20natriuretic%20peptide%20and%20coronary%20microvascular%20dysfunction%20in%20women%20with%20preserved%20ejection%20fraction:%20A%20report%20from%20the%20Women's%20Ischemia%20Syndrome%20Evaluation-Coronary%20Vascular%20Dysfunction&rft.jtitle=PloS%20one&rft.au=Jones,%20Erika&rft.date=2020-12-03&rft.volume=15&rft.issue=12&rft.spage=e0243213&rft.pages=e0243213-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0243213&rft_dat=%3Cgale%3EA643673257%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g997-8596d73a64f547f57a1d604418ee917cc17ef3331443bff5974e842518906cb43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A643673257&rfr_iscdi=true |